Mereo BioPharma
MREO
14 hedge funds and large institutions have $4.08M invested in Mereo BioPharma in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 4 closing their positions.
0.59% less ownership
Funds ownership: 1.86% → 1.27% (-0.59%)
13% less funds holding
Funds holding: 16 → 14 (-2)
22% less capital invested
Capital invested by funds: $5.21M → $4.08M (-$1.13M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$14.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$1.52M |
| 2 |
BC
Birchview Capital
Burlington,
Vermont
|
-$231K |
| 3 |
Primecap Management
Pasadena,
California
|
-$208K |
| 4 |
Renaissance Technologies
New York
|
-$102K |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
-$66.5K |
MREO Hedge Fund Activity: Q4 2019 in Review
14 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Mereo BioPharma (MREO) for Q4 2019, worth a combined $4.08M — down 22% from $5.21M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of MREO and 2 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $14.9K. The largest seller was BVF Inc, exiting entirely with an estimated $1.52M sold.
- 14 institutional investors held Mereo BioPharma (MREO) as of Q4 2019, down from 16 in Q3 2019.
- Funds reported $4.08M of Mereo BioPharma stock for Q4 2019, down 22% quarter-over-quarter.
- 2 funds opened new Mereo BioPharma positions in Q4 2019 and 4 closed out, a net change of -2 holders.
- The largest Mereo BioPharma buyer in Q4 2019 was UBS Group, an estimated $14.9K added.
- The largest Mereo BioPharma seller in Q4 2019 was BVF Inc, an estimated $1.52M sold.
Based on aggregated 13F filings for Q4 2019.